<DOC>
	<DOCNO>NCT01753674</DOCNO>
	<brief_summary>Our hypothesis TA-65 , dietary supplement help reduce insulin resistance plasma glucose individual classify metabolic syndrome .</brief_summary>
	<brief_title>The Effects Telomerase Activator TA-65 Insulin Resistance , Inflammation , Metabolic Syndrome</brief_title>
	<detailed_description>This double blind cross randomize clinical trial . The supplement placebo provide TA Science , Inc. prepare describe . Subjects randomly allocate consume either daily serve TA-65 ( two capsule per day 8 mg ) ( please see attached label ) placebo 12 week . Randomization do sequential manner ; first subject allocate supplement A next one supplement B . After 3-week washout , allocated alternate treatment additional 12 week . Supplements ( TA-65 placebo ) take twice daily meal . Participants advise change diet exercise protocol 27 week intervention . Volunteers require provide 5-day dietary record start study , end supplement period ( TA-65 placebo ) end washout period . Subjects fill exercise questionnaire time ensure change physical activity . Participants ask report department every 4 week check compliance supplement intake ass weight blood pressure .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>The inclusion criterion : men woman ( 4070 ) metabolic syndrome mean least 3 follow characteristic : Blood pressure &gt; 130/85 mm Hg plasma glucose &gt; 100 mg/dL plasma triglyceride &gt; 150 mg/dL HDL cholesterol &lt; 40 mg/dL ( men ) &lt; 50 mg/dL ( woman ) waist circumference &gt; 102 cm ( men ) â‰¥ 88 cm ( woman ) Women childbearing age use contraception Exclusion criterion selfreported diabetes mellitus coronary heart disease triglyceride great 400 mg/dL Fasting glucose great 126 mg/dL Blood pressure great 140/100 mmg Hg history stroke Use alcohol elevate rate ( two drink per day ) Renal problem liver disease cancer pregnancy lactation severe infectious disease autoimmune disease currently treatment current hormone therapy previous treatment TA65 . Intake glucoselowering prescription Use immunosuppressant , lithium supplement Sulphonylureas ( Glucotrol , Amaryl ) , Thiazolidinedione ( Avandia , ACTOS , ) , Meglitinides ( Prandin , Starlix ) , Biguanides ( Metformin ) , Alphaglucosidase inhibitor ( Precose , Glyset ) , dipeptidyl peptidase ( DPP ) 4 inhibitor ( Januvia , Onglyza ) high dose chromium cinnamon supplement Consistent intake vitamin , mineral , multivitamin supplement prior recruitment may admit study plan maintain current supplement program . However , subject may participate begin take new supplement 27wk study period . Subjects also ask refrain take additional supplement , include fish oil , herb concentrate antioxidant source .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>metabolic syndrome , insulin resistance , HDL cholesterol ,</keyword>
</DOC>